Biomanufacturing in China: Technologies and Facility Design

510 views
358 views

Published on

Join us as we DISCOVER, ANALYZE and LEARN the current state of the global biomanufacturing industry and the future growth potential and recent developments in Asia.

Some of the Key Highlights You Won’t Want to Miss Include

USA
Smart & Flexible Manufacturing Solutions in Multi-Product Facilities
Franz Walz, Executive Director Global Manufacturing, Science and Technology & Network Coordination, BOEHRINGER INGELHEIM

EUROPE
MAb Manufacturing Facilities for China & Automated Single-Use Processing to Bring Control & Flexibility to Manufacturing
Pauline Nicholson, Global Product Manager, Allegro Single-Use Systems, PALL
Niels Guldager, Senior Technology Partner, NNE PHRAMAPLAN

KOREA:
How to Bring Global Biopharmaceutical Capability through its Fully-Integrated Production Facilities?
Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS

SINGAPORE
What do Investors Look for When Investing in Biologics Manufacturing?
Steven Lee, Global Head of Biologics Tech Operations & Managing Director, DR. REDDY'S LABORATORIES

INDIA
Developing a Multiproduct Facility for Biosimilars & Engineering & Biomanufacturing of Enzymes for Different Applications
Arvind Mishra, Global Head of Quality & Regulatory & Head of Strategic Business Unit, Biologicals,
CADILLA PHARMACEUTICALS
Ravindra Wagh, Vice President, ZYDUS BIOLOGICS
Rajeev Soni, Senior Manager, R&D, NOVOZYMES

HONGKONG
What are the Experiences & What is the Future for the Investors in the Biomanufacturing Space?
Ramesh Rajentheran, Head of Asian Healthcare Investment Banking, BARCLAYS
Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT

INDONESIA
Improving Quality Control & Maintenance of Global Biological Product Distribution
Galatia Chandra, Head of Sales & System, Global Operation, KALBE INTERNATIONAL PTE LTD

http://www.biomanufacturing-asia.com

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
510
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Biomanufacturing in China: Technologies and Facility Design

  1. 1. Produced by: Associations: International Marketing Partner: www.biomanufacturing-asia.com Increasing Production, Enhancing Quality & Optimizing Operations Part of PRODUCTION BIOPHARMA DEVELOPMENT & WEEK 20 — 23 May 2014 Grand Hyatt Shanghai, China IBC LIFE SCIENCES PLUS: • WUXI APPTEC • SANOFI • NOVARTIS • TAKEDA PHARMACEUTICAL • BAXTER & many more! BIOBIO 4TH ANNUAL Jingrong Li Executive Director, Biologics, SIMCERE PHARMACEUTICALS, CHINA Key Conference Themes: • Regulations, GMP & Standards • Successful Partnerships, Investment & Financing • Effective Planning, Facility Design & Development • Improving Operations & Supply Chain Management • Cost Effective Single-Use Systems & Technology Transfer Steven Lee Global Head of Biologics Tech Operations & Managing Director, DR. REDDY’S LABORATORIES, SINGAPORE THE 2014 NEW EXPERT FACULTY INCLUDES: Ting Xu Founder & CEO, ALPHAMAB, CHINA Racho Jordanov President & CEO, JHL BIOTECH, TAIWAN PRE-CONFERENCE WORKSHOP: 20 MAY 2014 Biomanufacturing Technologies & Facility Design POST-CONFERENCE WORKSHOP: 23 MAY 2014 Meeting International Quality & Regulatory Requirements in Biomanufacturing Media Partners: Jeremy Caudill Global VP Business Development, SAMSUNG BIOLOGICS, KOREA Darren Ji Global Head, Asia Emerging Markets Partnering, F. HOFFMANN-LA ROCHE, CHINA Life Sciences
  2. 2. REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com 12.50 Networking Lunch & VIP Tables VIP Table 1: Jian Dong, DeputyGeneralManager, SHANGHAI UNITED CELL BIOTECHNOLOGY, CHINA VIP Table 2: Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS, KOREA If you would like to be seated on a table with the above guests in an exclusive lunch setting, please register your interest with gladys.landicho@ibcasia.com.sg. Limited seats are available! 2.30 Examining the Impact of the US H.R. 3204 Drug Quality & Security Act in the Biomanufacturing Industry • What are the substandard or counterfeit medicines & where are counterfeit medicines found? • To what extent could substandard medicine be considered as counterfeit & what should be done to ensure the safety, efficacy & quality of medicines? • Dealing with corruption & conflict of interest & what consumers should do? • How to boost security in the biopharmaceutical supply chain? • Understanding the effects of traceability requirement in the supply chain partners & pharmacies Masih Sabet, Associate Director, Quality Assurance, UCB, CHINA PARTNERSHIPS, INVESTMENT & FINANCING 3.00 Critical Success Factors for Choosing the Right Biomanufacturing Outsourcing Partner • What are the essential partner attributes to look for when selecting a partner? • Identifying the best technology capacity • Determining the partner’s expression platform • Maximizing the outsourcing opportunities in Asia Kang Li, Head of Biologics, BEIGENE, CHINA 3.30 Afternoon Networking & Refreshment Break 4.00 What do Investors Look for When Investing in Biologics Manufacturing? • Examining business models & growth strategies • Attracting foreign investors • Ensuring financial security in the biomanufacturing business • Selecting & managing partners ~ Prototyping ~ Negotiating StevenLee, GlobalHeadofBiologicsTechOperations&ManagingDirector, DR. REDDY’S LABORATORIES, SINGAPORE 4.30 Venture Capital & Private Equity in the Biomanufacturing Space – What are the Experiences & What is the Future for Investors? • Understanding the growing pipeline of biologics portfolio • What are the current trends in the biomanufacturing industry in Asia? • What are the investment opportunities for entering the biomanufacturing market in China as compared to other countries in Asia? • What are the risks involved in investing in the biomanufacturing industry? Panelists: Ramesh Rajentheran, Head of Asian Healthcare Investment Banking, BARCLAYS, HONG KONG Nisa Leung, Managing Partner, QIMING VENTURE PARTNERS, CHINA Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT, HONG KONG 5:30 Chairperson’s Summary of Day One 6.00 Speed Networking & Networking Cocktail VIP 1: Atul Deshpande, Associate Director, Unit Strategy Officer, Asia Pacific, SANOFI, CHINA VIP 2: Sune Duus Svenningsen, Head of Operations, Asia Pacific, NOVARTIS, CHINA Exclusive to Registered Participants Only: Limited Spots Available! Participants have the chance to spend two minutes getting to know the below key experts in the Biopharma Industry! Secure your place today with gladys.landicho@ibcasia.com.sg 7.00 End of Conference Day One DAY ONE 21 May 2014 | Wednesday 08:00 Registration Opens & Morning Coffee 08:50 Welcome Address from IBC Asia & Ice Breaker Exchange Business Cards & Get To Know Industry Peers 09:00 Chairperson’s Opening Remarks BIOPHARMA VISIONARY KEYNOTE SESSIONS 09:05 Global Biopharma Outlook • Trends in the global biopharma industry • Priorities of investment in China & opportunities for growth • Challenges & opportunities in the Asian region • The role of Biosimilars in the region’s biopharma industry • Key criteria to further the development of the sector in China and Asia Moderator: Scott Liu, CEO, HENLIUS PHARMACUETICALS, CHINA Panelists: Youling Wu, CEO, ZHEJIANG TERUISI, CHINA Jianguo Yang, Principal Scientist, SANOFI GENZYME, USA Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS, KOREA Abdullah Baaj, CEO, BOSTON ONCOLOGY, USA Sameer Agarwal, Senior Vice President, Business Center Strategic Marketing, Business Unit Generic Drugs & Standard Solutions, FRESENIUS KABI DEUTSCHLAND GMBH, GERMANY 09:50 Biopharma Regulatory Updates & Development • Clinical approvals for biopharmaceuticals • Regulatory differences between the FDA/EMA/ICH & local agencies in China & other emerging markets such as India & SEA • How to demonstrate process consistency & what is required? • Accelerating IND applications • Updates on Biosimilars guidelines in key Asian markets Panelists: Victoria Elegant, Vice President, Medical & Regulatory Affairs, BAXTER, CHINA Andrea Laslop, Head of Scientific Office, AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY (AGES) PHARMMED, AUSTRIA & Austrian Member, Committee for Human Medicinal Products (CHMP), EUROPEAN MEDICINES AGENCY (EMA), AUSTRIA Dr.ArvindMishra,GlobalHeadofQuality&Regulatory&HeadofStrategic Business Unit, Biologicals, CADILLA PHARMACEUTICALS, INDIA BIOPHARMA TECHNOLOGY SHOWCASE 10:30 Cutting Edge Solutions & Innovation in Biopharma If you have leading edge technology & solutions & would like to showcase your innovation in front of biopharma industry stakeholders, please contact Yvonne Leong: Yvonne.leong@ibcasia.com.sg 11:00 Morning Networking & Refreshment Break 11.45 Chairperson’s Opening Remarks Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS, KOREA QUALITY & GMP STANDARDS 11.50 Bridging the Quality Differences of China GMP Standards vs. Europe & the US • Examining the quality assurance procedures • Analyzing the facility requirements • Assessing differences in standards • Determining the effects vs. quality of products outsourced from China JingrongLi, ExecutiveDirector,Biologics, SIMCEREPHARMACEUTICALS, CHINA 12.10 Developing a Multiproduct Facility for Biosimilars According to GMP Standards • Risk management techniques during design • Does the multiproduct facility affect the product? • Cleaning validation study for multi-product equipment • Identifying the best multiproduct facility management strategies Shaligram Rane, Vice President, Quality, INTAS PHARMACEUTICALS LTD, INDIA 12.30 The US FDA Quality Inspection Standards for Biological Products Manufactured in China • Examining the facility, management & control system • Ensuring the quality of the biological products manufactured in China are up to US FDA standards • Comparing how the US FDA & CFDA define a state of control for: ~ Plant layout ~ Smooth work flows ~ Efficient documentation systems ~ Well controlled processes • What are the strategies on how to prepare for an inspection? • How to deal with the inspector? What to communicate & how to communicate effectively with an inspector? Shaoyu Chen, Managing Director, China Food & Drug Practice, COVINGTON & BURLING LLP, CHINA & Former, Assistant Chief Counsel, FOOD AND DRUG ADMINISTRATION, USA REGULATORY LEADERSPANEL PANELDISCUSSION
  3. 3. PANELDISCUSSION 12.00 Networking Luncheon & VIP Lunch Tables VIP Table 1: Sune Duus Svenningsen, Head of Operations, Asia Pacific, NOVARTIS, CHINA VIP Table 2: Darren Ji, Global Head, Asia & Emerging Markets Partnering, F. HOFFMANN-LA ROCHE, CHINA If you would like to be seated on a table with the above guests in an exclusive lunch setting, please register your interest with gladys.landicho@ibcasia.com.sg. Limited seats are available! BIOMANUFACTURING TECHNOLOGIES & TECHNOLOGY TRANSFER 2.00 Developing a Robust Commercial Process for Technology Transfer: Ensuring Product Comparability to Avoid Rejection • Comparative protocols to demonstrate the same quality of products produced • What could be the impact of technology transfer? ~ Manpower ~ Cost ~ Quality • To what extent can the R&D process be copied? Rajeev Soni, Associate Vice President, Research & Development, BIOCON, INDIA 3.00 Afternoon Networking & Refreshment Break 3.30 To What Extent Could Disposable Technologies Be a Commercial Manufacturing Technology in China? • What are the requirements from the government? • Examining the validation of lethable and extractable. Is it safe to do? • Examining the growth potential & opportunity for disposable technologies Panelists: Lei Sun, Vice President, Technology & Manufacture, AUTEKBIO, CHINA Jason Li, Senior Director, Downstream Processing, GENOR BIOPHARMA, CHINA Racho Jordanov, President & CEO, JHL BIOTECH, TAIWAN Jimmy Li, Executive Director of Biologics & Bioprocesses, WUXI APPTEC, CHINA ROUND TABLE DISCUSSIONS 4:30 Round Table Discussions Financing & Investment Opportunities in the Biomanufacturing Industry Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT, HONGKONG Examining Disposable Solutions Jason Li, Senior Director, Downstream Processing, GENOR BIOPHARMA, CHINA Optimizing Operations in Biomanufacturing Sune Duus Svenningsen, Head of Operations, Asia Pacific, NOVARTIS, CHINA Limited Seats Are Available! Secure your place with gladys.landicho@ibcasia.com.sg 5:30 Chairperson’s Summary of the Day & End of Conference REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com DAY TWO 22 May 2014 | Thursday 08.55 Chairperson’s Opening Remarks JeremyCaudill, GlobalVPBusinessDevelopment, SAMSUNGBIOLOGICS, KOREA BIOMANUFACTURING PLANNING, FACILITY DESIGN & DEVELOPMENT 09.00 Setting up A Vaccine Manufacturing Facility in China: What to Do & What to Expect? • Overview of the China vaccine market • Identifying the key success factors to set up a vaccine business in China • Understanding the business penetration model in China • What are the innovative approaches & best practices in vaccine manufacturing? Homer He, Vice President, SHANGHAI LEIYUNSHANG WEST PHARMACEUTICAL & General Manager, SHANGHAI JINGAN PHARMACEUTICAL, CHINA 9.20 Biomanufactuing Production Capacity Planning, Scale Up & Development • Production capacity planning & considerations • Successful comparability study design between pilot scale & commercial scale • Determining the proper commercial scale in biologics ~ Designing & planning procedures • Reducing animal source materials in biomanufacturing Yong Ho Ahn, Vice President & Head of Biosimilar & Process Development, HANHWA BIOLOGICS, KOREA 9.40 Opportunities & Development for Follow-on Complex Biologics Production • In depth understanding of complex biologics, Abetacept • Understanding the development of Abetacept biosimilar • Analysing the QbD approach during Abatacept development Ting Xu, CEO & President, ALPHAMAB, CHINA 10:00 Morning Networking & Refreshment Break OPTIMIZING OPERATIONS & SUPPLY CHAIN MANAGEMENT 10.30 Improving Quality Control & Maintenance of Global Biological Product Distribution • Engaging the different distribution channels • Warehousing & distribution procedures • Appropriate storage condition • Engaging third party suppliers Galatia Chandra, Head of Sales & System, Global Operation, KALBE INTERNATIONAL PTE LTD, INDONESIA 11.00 Best Practices in Cold Chain Temperature Mapping for Biopharmaceutical and Pharmaceutical Products • Analyzing the importance of cold chain temperature mapping in biomanufacturing • Understanding complexities of the supply chain • Is there an overlap between GDP & GMP? • What are the bulk pharmaceutical shipment systems between upstream & downstream processing facilities? Omar Tabanjeh, Associate Director, Head of Quality Assurance, Middle East, Turkey & Africa, TAKEDA PHARMACEUTICALS, UAE 11.30 Analyzing the Biomanufacturing Supply Chain Challenges & Potential Solutions • How regulatory challenges affect launching new products in terms of patency & GMP issues? • What are the financial risky challenges that shape the supply chain strategy in case of unexpected currency change rates? • How politics influence the Supply Chain Manager’s decisions? • Contracting & importing biopharmaceuticals Mina Ghaly, Head of Procurement Office, EVA PHARMA, CHINA
  4. 4. Biomanufacturing Technologies & Facility Design The purpose of this workshop is to acquaint the participant with current technology trends in biomanufacturing and key facility design concepts. 8.30 Registration 8.50 Introduction 9.00 Session 1: Biomanufacturing Landscape in China • Existing biomanufacturing facilities in China • Recent additions and on-going plans for new facilities 10.00 Session 2: Facility Size & Scales • Factors to consider in deciding manufacturing scales • Large vessel vs multiple smaller vessels? 10.45 Coffee Break 11.15 Session 3: Manufacturing Technologies: Disposable vs. Stainless Steel • Pros & cons of disposable & stainless steel facilities • How should the decision be made – factors to consider? 12.00 Networking Lunch Break 13.30 Session 4: Facility Design – Basic Concepts • Key concepts for facility design • Facility design steps & timelines 14.30 Session 5: Facility Design – Process Design Concepts • How should process design integrate with facility design? • Process design principles 15.00 Coffee Break 15.30 Session 6: Design of Drug Product (Fill Finish) Facility • Challenges in drug product facility design • Examples of a drug product facility 16.15 Session 7: Facility Start-Up & Commissioning • Key activities/milestones in facility start-up • Case study: 1st cGMP biologics facility start-up & commissioning 17.15 Closing Remarks & End of Workshop Meeting International Quality & Regulatory Requirements in Biomanufacturing The purpose of this workshop is to acquaint the participant with a strong understanding of how to improve their regulatory submissions & quality systems, & how to successfully pass a foreign inspection. 8.30 Registration 8.50 Introduction 9.00 Session 1: Preparation of Clinical Trial Applications (CTA) • CTA & Investigational New Drug (IND) applications for Europe & the US • Guide to the preparation of documents • Key issues and common pitfalls 10.00 Session 2: Good Record Keeping in Support of Regulatory Applications • Understanding the value of development reports • Key writing skills for clear communication 10.30 Coffee Break 11.00 Session 3: Drug Master Files & Facility Registration • Types of drug master files in Europe and US • How to prepare & submit a master file? • How to register your facility? 12.00 Networking Lunch Break 13.30 Session 4: Quality Systems • Key Quality Systems for international cGMP • How to establish & organize your quality program? 14.30 Session 5: Current Quality Issues • Current topics in Quality Assurance • Examples & case studies of real problems 15.00 Coffee Break 15.30 Session 6: Preparing for Inspections & Audits • How to prepare your company for foreign inspections and audits? • How to work with inspectors & auditors? • How to reply to observations? 16.30 Session 7: cGMP Facility Design • Variations in requirements between different regulatory agencies • Basic principles for facility • Review of facility examples 17.30 Closing Remarks & End of Workshop REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com WORKSHOPS PRE-CONFERENCE WORKSHOP: 20 MAY 2014 • Tuesday POST-CONFERENCE WORKSHOP: 23 MAY 2014 • FRIDAY Jincai (Jimmy) Li Executive Director of Biologics & Bioprocesses, WUXI APPTEC, CHINA Scott M. Wheelwright Co-Founder & Principal Consultant, COMPLY ASIA CO. LTD, CHINA About Your Workshop Leader About Your Workshop Leader Dr. Jincai (Jimmy) Li is responsible for cell culture process development as well as operation of the non-GMP pilot plant. He has extended experience in both mammalian cell culture and microbial fermentation. His expertise includes recombinant protein, especially monoclonal antibody expression and process development, scale-up, technology transfer, process characterization and validation, as well as post-marketing process improvement. Before joining Wuxi, Dr. Li was Sr. Engineer and Group Leader at Genentech Inc., where he led a group responsible for cell culture process development. He participated in multiple monoclonal antibody therapeutic projectsí cell culture process development, clinical material production, IND submission and also in several Phase III as well as post-marketing products’ tech transfer and process characterization/validation work. In addition, Dr. Li was also a core member of the team that developed Genentech’s next-generation chemically-defined cell culture medium and process platform, and his team developed the record 9+ g/L cell culture process at Genentech. Before Genentech, Dr. Li also worked atTanox, Inc., where he led the manufacturing sciences group supporting PhIII production of a mAb product, and at Diversa Corporation (now Verenium), in charge of process development for multiple recombinant enzyme projects. Dr. Li is the author of over a dozen peer-reviewed publications and patents. Dr.Wheelwright has 30 years of hands on expertise quality assurance, regulatory, manufacturing and process development. He has directly participated in developing oncology, infectious disease, cardiovascular, wound healing, angiogenesis, vaccine and diagnostic products. Dr. Wheelwright has been an executive officer in several biotech startups, and has supervised the areas of manufacturing, process development, compliance, quality assurance, quality control, validation, engineering and facilities. He has led the development of several products that are now on the market and has led the construction of multiple manufacturing facilities that meet cGMP requirements. His corporate experience includes Abbott, Chiron (now Novartis) and Scios (now J&J). Dr. Wheelwright served as the founding COO for Innovent, a biopharmaceutical company in China, and is founder and president of Strategic Manufacturing Worldwide, Inc., a consulting firm that provides business and technical expertise to biotech and related industries. Dr. Wheelwright obtained his PhD degree in chemical engineering from the University of California at Berkeley and performed post-doctoral studies in biophysics at the Max Planck Institute in Germany. He is the author of a book on protein purification and has published many papers on process design, manufacturing, and compliance for pharmaceuticals and biologics. PRE-CONFERENCE WORKSHOP: 20 MAY 2014 POST-CONFERENCE WORKSHOP: 23 MAY 2014
  5. 5. REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com About the BDP Week The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia. Visit www.biopharmaproduction.com for more information. Co-Located with: 30+ Top Level Speakers New Pre & Post Interactive Workshops 4 Interactive Panel Discussions Hot Topic Round Table Discussions Meet the Experts Via Specially Hosted VIP Lunch Tables Speed Networking Sessions Morning Ice Breaker & Get to Know your Peers Conference Cocktail Acceleron Pharma • AlphaMab • Amgen • Autekbio • Bayer HealthCare • Berna Biotech Korea • Biopharm Services • BioPharmaNeer Alliance • Bioprocessing Technology Institute • Boehringer Ingelheim • Bristol-Myers Squibb • Celltrion Healthcare • Chugai Pharmaceutical • CMC Biologics • CMC Biologics • Compliance Concepts International • Daewoong Pharmaceutical • DMS Biotechnology • Dow Corning • ExcellGene • Genor Biopharma • Genzyme/Sanofi • Indian Immunologicals • Innobiologics • Innovent Biologics • Mass Biologics • Novasep • Pfizer Biotherapeutics • Sartorius Stedim Biotech • Saint Gobain • SFDA Training Center • Shanghai Henlius Biotech • Swiss Federal Institute of Technology • Wuxi Apptec • Yooyoung Pharmaceutical & many more 20 — 23 May 2014 Grand Hyatt Shanghai, China Part of PRODUCTION BIOPHARMA DEVELOPMENT & WEEK Asian countries such as India, Singapore, South Korea & China are fast becoming biomanufacturing hubs. Biologics manufacturing is a huge investment & can amount to US10 million or more to construct, equip, & launch a successful certified GMP plant facility (Biospectrum Asia, 2013). With the intensifying growth & demand of biologics production, IBC’s 4th Annual Biomanufacturing Conference provides a timely platform to explore the opportunities & challenges faced in this sector including: The investment opportunities for entering the biomanufacturing market in China & the surrounding Asian region Bridging the quality differences of China GMP Standards vs. Europe & the US What is the growth potential & opportunity for disposable technologies in biomanufacturing in China? Identifying the critical factors in choosing the right outsourcing partner Developing a robust commercial process for technology transfer Examining the impact of the US H.R. 3204 Drug Quality & Security Act in the biomanufacturing industry For sponsorship opportunities, contact Yvonne Leong at Tel: +65 6508 2489 Email: Yvonne.leong@ibcasia.com.sg BY INDUSTRY ■ Biopharmaceutical / Pharmaceutical / Biotechnology 45% ■ Technology and Solution Service Providers 20% ■ CMO 15% ■ Research Institutes 10% ■ Government 10% www.biosimilarasia.com www.celllineasia.com LIMITED SPONSORSHIP & EXHIBITION OPPORTUNITIES AVAILABLE Do you provide innovative technology to support the biomanufacturing Industry in Asia? • Showcase the latest technology • Meet & network with senior decision makers in Asia • Position your brand as the market leader to stand out amidst competition • Generate new business contacts & strengthen existing accounts Who Should Attend SNAPSHOT OF PAST ATTENDING COMPANIES INCLUDE: Abundant Networking Opportunities & Interactive Formats! AnInternationalEvent China, Taiwan, Hong Kong 55% Europe 10% USA 5% Australia 5%Southeast Asia 10% Japan, Korea 10% India 5%
  6. 6. GROUP BONUS: REGISTER 3 DELEGATES FROM THE SAME COMPANY AND THE 4TH ATTENDS FOR FREE! CREDIT CARD PAYMENTS The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at www.biomanufacturing- asia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest confidence, please do not send payment details by email. Credit card contact: Department: Direct phone number: Email: Grand Hyatt Shanghai, China Jin Mao Tower, 88 Century Boulevard Pudong, Shanghai 200121 Tel: +86 21 5049 1234 | Fax: +86 21 5049 8381 Contact Person: Judy Xu Email: judy.xu@hyatt.com ENJOY SUBSTANTIAL SAVINGS WITH OUR MULTIPLE BOOKING DISCOUNT! Early Bird Rate Register & pay on or before 14 Mar 2014 FEE PER DELEGATE Special Rate Register & pay before 11 Apr 2014 Group Rate (3 or more delegates) Normal Rate Register & pay after 11 Apr 2014 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Tel: +65 6508 2400 Fax: +65 6508 2408 REGISTER NOW! FAX BACK TO +65 6508 2407 HOTEL INFORMATION DATA PROTECTION PAYMENT TERMS CANCELLATION / SUBSTITUTION IMPORTANT NOTE This label contains your priority booking code. To expedite registration, please do not remove label. If you have already received a copy of this brochure, we apologise. For reasons of confidentiality, your full particulars were not available to IBC Asia (S) Pte Ltd for deduplication prior to mail drop. 6 EASY WAYS TO REGISTER REGNO.200108203N 4th Annual BioManuacturing RESERVE YOUR PLACE TODAY! P46238 USD 2,695 USD 2,895 USD 2,995 USD 2,495 If undelivered, please return to: MAIL the attached registration form with your cheque to IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Email register@ibcasia.com.sg Fax +65 6508 2407 Web www.biomanufacturing-asia.com SAVE WITH THE EARLY BIRD & SPECIAL RATES! Scan the QR Code with your smartphone and register today The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Occasionally, your details may be obtained from or shared with external companies who wish to communicate with you offers related to your business activities. If you do not wish your details to be used for this purpose, please contact our Database Department at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or Fax: +65 6508 2408. Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event. Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407). Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC assumes no further liability or obligation, beyond the refund of the paid registration fee, in the event of postponement or cancellation by IBC. ❑ Yes! I/We will attend the 4th Annual BioManufacturing 20 – 23 May 2014, Grand Hyatt Shanghai, China ❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in. Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut-off date. All payments should be made in US or CNY dollars. • Payments by US$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” and mailed to: IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Attn: The Accounts Receivable Team • Payment by telegraphic transfer in US$ must be made to: IBC Asia (S) Pte Ltd A/C No.: 260-457866-178 (USD) The Hongkong and Shanghai Banking Corporation Limited, 21 Collyer Quay, HSBC Building, Singapore 049320 Bank Swift Code: HSBCSGSG Bank Code: 7232 • Payment by telegraphic transfer in CNY must be made to: A/C Name: Conferences and Event Management Services (Shanghai) Co., Ltd. A/C No.: 720-031103-001 Beneficiary Bank: Bank (China) Company Limited Bank Address: No. 1000 Lujiazui Rind Road, Pudong, Shanghai 200120, P.R. China • Payment by credit card in US$ (AMEX, VISA or MasterCard) The best way to pay by credit card is through our secure portal built into the website. To pay by phone please indicate the contact name and details below and our Customer Services Team will call within 24 hours to take payment. Please do not send credit card information by email. HSBC IBC USD 2,295 USD 2,495 USD 2,595 USD 2,095 International Companies USD 1,695 USD 1,895 USD 1,995 USD 1,495 China Domestic Companies CNY 6,500 CNY 7,500 CNY 8,000 CNY 6,000 CNY 5,500 CNY 6,500 CNY 7,000 CNY 5,000 CNY 4,500 CNY 5,500 CNY 6,000 CNY 4,000 Who is Head of your Department? Who is Head of Training? Company Information Company Name: Address: Main Business/Activity: Postal Code: Please photocopy for additional delegates FREE GROUP DISCOUNT Delegate 1 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 2 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 3 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 4 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate. • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel. • Registration fees are subject to the prevailing government tax International companies have Global Headquarters located outside mainland China. A China domestic company has its global headquarters located within mainland China. Regulatory Authorities, Government and Academia will be accorded 40% off Normal Rates Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd ❑ I am paying by bank transfer (copy attached) ❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted) Customer Service Hotline +65 6508 2401 [Singapore] +86 21 2326 3680 [China] ❑ 2 Day Package - 2 Day Conference only ❑ 4 Day Package - 2 Day Conference + Pre & Post Workshops ❑ 3 Day Package - 2 Day Conference + ❑ Pre OR ❑ Post Workshop ❑ 2 Day Package - 2 Day Conference only ❑ 4 Day Package - 2 Day Conference + Pre & Post Workshops ❑ 3 Day Package - 2 Day Conference + ❑ Pre OR ❑ Post Workshop

×